Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Baker

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Drugs in Dermatology : JDD|July 10, 2003
The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparisonAlice B Gottlieb, Umesh Chaudhari, Daniel G Baker, et al.
The Journal of Rheumatology|April 3, 2016
Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics TrialsMaarten Boers, Daniel Aletaha, Christopher M Mela, et al.
Annals of the Rheumatic Diseases|June 21, 2015
Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritisJoshua F Baker, Philip G Conaghan, Paul Emery, et al.
Clinical and Experimental Rheumatology|January 31, 2017
Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progressionJoshua F Baker, Mikkel Østergaard, Paul Emery, et al.
Annals of the Rheumatic Diseases|July 20, 2016
Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritisJoshua F Baker, Philip G Conaghan, Paul Emery, et al.
The Journal of Rheumatology|April 21, 2007
Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate aloneSudha Visvanathan, Gregory F Keenan, Daniel G Baker, et al.
Journal of Strength and Conditioning Research|February 20, 2025
A Critical Appraisal of Using Barbell Velocity Data to Regulate TrainingSteven M Hirsch, Christopher J Chapman, Harjiv Singh, et al.
Annals of the Rheumatic Diseases|June 14, 2017
Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritisMichael D George, Mikkel Østergaard, Philip G Conaghan, et al.
Journal of the American Academy of Dermatology|June 6, 2003
Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasisAlice B Gottlieb, Umesh Chaudhari, Lisa D Mulcahy, et al.
Rheumatology (Oxford, England)|September 6, 2011
Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritisJoshua F Baker, Michael George, Daniel G Baker, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Drugs in Dermatology : JDD|July 10, 2003
The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparisonAlice B Gottlieb, Umesh Chaudhari, Daniel G Baker, et al.
The Journal of Rheumatology|April 3, 2016
Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics TrialsMaarten Boers, Daniel Aletaha, Christopher M Mela, et al.
Annals of the Rheumatic Diseases|June 21, 2015
Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritisJoshua F Baker, Philip G Conaghan, Paul Emery, et al.
Clinical and Experimental Rheumatology|January 31, 2017
Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progressionJoshua F Baker, Mikkel Østergaard, Paul Emery, et al.
Annals of the Rheumatic Diseases|July 20, 2016
Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritisJoshua F Baker, Philip G Conaghan, Paul Emery, et al.
The Journal of Rheumatology|April 21, 2007
Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate aloneSudha Visvanathan, Gregory F Keenan, Daniel G Baker, et al.
Journal of Strength and Conditioning Research|February 20, 2025
A Critical Appraisal of Using Barbell Velocity Data to Regulate TrainingSteven M Hirsch, Christopher J Chapman, Harjiv Singh, et al.
Annals of the Rheumatic Diseases|June 14, 2017
Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritisMichael D George, Mikkel Østergaard, Philip G Conaghan, et al.
Journal of the American Academy of Dermatology|June 6, 2003
Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasisAlice B Gottlieb, Umesh Chaudhari, Lisa D Mulcahy, et al.
Rheumatology (Oxford, England)|September 6, 2011
Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritisJoshua F Baker, Michael George, Daniel G Baker, et al.
Pageof 4